Haydu LE - Search Results

1

Is melphalan dose adjustment according to ideal body weight useful in isolated limb infusion for melanoma?

Huismans AM, Kroon HM, Haydu LE, Kam PC, Thompson JF. Huismans AM, et al. Among authors: haydu le. Ann Surg Oncol. 2012 Sep;19(9):3050-6. doi: 10.1245/s10434-012-2316-4. Epub 2012 Apr 24. Ann Surg Oncol. 2012. PMID: 22526898

2

Quality of histopathological reporting on melanoma and influence of use of a synoptic template.

Haydu LE, Holt PE, Karim RZ, Madronio CM, Thompson JF, Armstrong BK, Scolyer RA. Haydu LE, et al. Histopathology. 2010 May;56(6):768-74. doi: 10.1111/j.1365-2559.2010.03546.x. Histopathology. 2010. PMID: 20546342

3

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford RF. Long GV, et al. Among authors: haydu le. J Clin Oncol. 2011 Apr 1;29(10):1239-46. doi: 10.1200/JCO.2010.32.4327. Epub 2011 Feb 22. J Clin Oncol. 2011. PMID: 21343559

4

Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.

Lee NC, Spillane AJ, Pang TC, Haydu LE, Uren RF. Lee NC, et al. Among authors: haydu le. Ann Surg Oncol. 2012 Jan;19(1):280-6. doi: 10.1245/s10434-011-1872-3. Epub 2011 Jul 21. Ann Surg Oncol. 2012. PMID: 21833669

5

Ultrasound assessment of lymph nodes in the management of early-stage melanoma.

Thompson JF, Haydu LE, Sanki A, Uren RF. Thompson JF, et al. Among authors: haydu le. J Surg Oncol. 2011 Sep;104(4):354-60. doi: 10.1002/jso.21963. J Surg Oncol. 2011. PMID: 21858829 Review.

6

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA. Murali R, et al. Among authors: haydu le. Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72. Ann Surg. 2012. PMID: 21975320

7

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.

Wilmott JS, Long GV, Howle JR, Haydu LE, Sharma RN, Thompson JF, Kefford RF, Hersey P, Scolyer RA. Wilmott JS, et al. Among authors: haydu le. Clin Cancer Res. 2012 Mar 1;18(5):1386-94. doi: 10.1158/1078-0432.CCR-11-2479. Epub 2011 Dec 12. Clin Cancer Res. 2012. PMID: 22156613

8

Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Long GV, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Kefford RF, Thompson JF, Scolyer RA. Murali R, et al. Among authors: haydu le. Ann Surg Oncol. 2012 Jun;19(6):1782-9. doi: 10.1245/s10434-012-2265-y. Epub 2012 Feb 14. Ann Surg Oncol. 2012. PMID: 22350600 Clinical Trial.

9

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.

Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, Kefford RF, Scolyer RA, Long GV. Menzies AM, et al. Among authors: haydu le. Clin Cancer Res. 2012 Jun 15;18(12):3242-9. doi: 10.1158/1078-0432.CCR-12-0052. Epub 2012 Apr 24. Clin Cancer Res. 2012. PMID: 22535154

10

Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.

In 't Hout FE, Haydu LE, Murali R, Bonenkamp JJ, Thompson JF, Scolyer RA. In 't Hout FE, et al. Among authors: haydu le. Ann Surg. 2012 Jun;255(6):1165-70. doi: 10.1097/SLA.0b013e31824c4b0b. Ann Surg. 2012. PMID: 22566014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters